Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial

Invest Radiol. 1991 Nov:26 Suppl 1:S221-3; discussion S232-5. doi: 10.1097/00004424-199111001-00075.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Contrast Media / administration & dosage
  • Contrast Media / adverse effects*
  • Dose-Response Relationship, Drug
  • Drug Tolerance
  • Gadolinium / administration & dosage
  • Gadolinium / adverse effects*
  • Gadolinium DTPA
  • Germany
  • Humans
  • Infusions, Intravenous
  • Magnetic Resonance Imaging / methods
  • Organometallic Compounds / administration & dosage
  • Organometallic Compounds / adverse effects*
  • Pentetic Acid / administration & dosage
  • Pentetic Acid / adverse effects*
  • Single-Blind Method

Substances

  • Contrast Media
  • Organometallic Compounds
  • Pentetic Acid
  • Gadolinium
  • Gadolinium DTPA